The price of Alector Inc (NASDAQ: ALEC) closed at $6.97 in the last session, down -0.29% from day before closing price of $6.99. In other words, the price has decreased by -$0.02 from its previous closing price. On the day, 718996 shares were traded. ALEC stock price reached its highest trading level at $7.35 during the session, while it also had its lowest trading level at $6.90.
Ratios:
We take a closer look at ALEC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 14, 2023, Upgraded its rating to Buy and sets its target price to $15 from $8 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On September 25, 2023, Goldman started tracking the stock assigning a Sell rating and target price of $4.Goldman initiated its Sell rating on September 25, 2023, with a $4 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 04 when Rosenthal Arnon sold 23,831 shares for $5.56 per share. The transaction valued at 132,500 led to the insider holds 2,019,217 shares of the business.
Kenkare-Mitra Sara sold 12,519 shares of ALEC for $69,606 on Dec 04. The President and Head of R&D now owns 329,016 shares after completing the transaction at $5.56 per share. On Dec 04, another insider, Romano Gary, who serves as the Chief Medical Officer of the company, sold 5,035 shares for $5.56 each. As a result, the insider received 27,995 and left with 202,314 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALEC now has a Market Capitalization of 664.09M and an Enterprise Value of 115.46M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.82 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 1.19 whereas that against EBITDA is -0.81.
Stock Price History:
Over the past 52 weeks, ALEC has reached a high of $9.06, while it has fallen to a 52-week low of $3.66. The 50-Day Moving Average of the stock is 6.92, while the 200-Day Moving Average is calculated to be 6.46.
Shares Statistics:
According to the various share statistics, ALEC traded on average about 708.53K shares per day over the past 3-months and 571.76k shares per day over the past 10 days. A total of 84.88M shares are outstanding, with a floating share count of 69.86M. Insiders hold about 26.47% of the company’s shares, while institutions hold 66.06% stake in the company. Shares short for ALEC as of Feb 15, 2024 were 5.23M with a Short Ratio of 7.38, compared to 5.4M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.50% and a Short% of Float of 7.02%.
Earnings Estimates
The company has 8 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.52 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.79, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.38 and low estimates of -$0.81.
Analysts are recommending an EPS of between -$0.85 and -$2.91 for the fiscal current year, implying an average EPS of -$1.93. EPS for the following year is -$1.9, with 10 analysts recommending between -$1.37 and -$2.5.
